Association between periodontal disease and microstructural brain alterations in the Hamburg City Health Study
Journal of Clinical Periodontology · 2024
DOI: 10.1111/jcpe.13828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2024. Verfasst von Carola Mayer und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Periodontal Diseases, Cerebral Small Vessel Diseases, Magnetic Resonance Imaging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, University Medical Center Hamburg-Eppendorf.
Abstract (Originalsprache)
Aim
The aim of the PAROBRAIN study was to examine the association of periodontal health with microstructural white matter integrity and cerebral small vessel disease (CSVD) in the Hamburg City Health Study, a large population‐based cohort with dental examination and brain magnetic resonance imaging (MRI). Materials and Methods Periodontal health was determined by measuring clinical attachment loss (CAL) and plaque index. Additionally, the decayed/missing/filled teeth (DMFT) index was quantified. 3D‐FLAIR and 3D‐T1‐weighted images were used for white matter hyperintensity (WMH) segmentation. Diffusion‐weighted MRI was used to quantify peak width of skeletonized mean diffusivity (PSMD).
Results
Data from 2030 participants were included in the analysis. Median age was 65 years, with 43% female participants. After adjusting for age and sex, an increase in WMH load was significantly associated with more CAL, higher plaque index and higher DMFT index. PSMD was significantly associated with the plaque index and DMFT. Additional adjustment for education and cardiovascular risk factors revealed a significant association of PSMD with plaque index ( p < .001) and DMFT ( p < .01), whereas effects of WMH load were attenuated ( p > .05).
Conclusions
These findings suggest an adverse effect of periodontal health on CSVD and white matter integrity. Further research is necessary to examine whether early treatment of periodontal disease can prevent microstructural brain damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Periodontics, Preventive and Restorative Dentistry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Prosthetic Dentistry, Center for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Psychiatry, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
ORCID-Profile: Carola Mayer, Carolin Walther
Förderung
- Deutsche Forschungsgemeinschaft
- University Medical Center Hamburg-Eppendorf
Zitieren
APA
Mayer, C., Walther, C., Borof, K., Nägele, F. L., Petersen, M., Schell, M., Gerloff, C., Kühn, S., Heydecke, G., Beikler, T., Cheng, B., Thomalla, G., & Aarabi, G. (2024). Association between periodontal disease and microstructural brain alterations in the Hamburg City Health Study. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.13828
Vancouver
Mayer C, Walther C, Borof K, Nägele FL, Petersen M, Schell M, et al. Association between periodontal disease and microstructural brain alterations in the Hamburg City Health Study. Journal of Clinical Periodontology. 2024. doi:10.1111/jcpe.13828
BibTeX
@article{Mayer2024,
author = {Mayer, Carola and Walther, Carolin and Borof, Katrin and Nägele, Felix L and Petersen, Marvin and Schell, Maximilian and Gerloff, Christian and Kühn, Simone and Heydecke, Guido and Beikler, Thomas and Cheng, Bastian and Thomalla, Götz and Aarabi, Ghazal},
title = {Association between periodontal disease and microstructural brain alterations in the Hamburg City Health Study},
journal = {Journal of Clinical Periodontology},
year = {2024},
doi = {10.1111/jcpe.13828}
}
EUVIMED